Cresset Asset Management’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$294K Buy
3,257
+156
+5% +$13.2K ﹤0.01% 1396
2026
Q1
$259K Sell
3,101
-123
-4% -$10.1K ﹤0.01% 1345
2025
Q4
$295K Buy
3,224
+210
+7% +$20.1K ﹤0.01% 1306
2025
Q3
$286K Buy
3,014
+443
+17% +$41.7K ﹤0.01% 1266
2025
Q2
$269K Sell
2,571
-2,776
-52% -$263K ﹤0.01% 1177
2025
Q1
$473K Buy
5,347
+1,317
+33% +$135K ﹤0.01% 1094
2024
Q4
$387K Sell
4,030
-288
-7% -$26.8K ﹤0.01% 1208
2024
Q3
$353K Buy
4,318
+721
+20% +$55.6K ﹤0.01% 1723
2024
Q2
$310K Buy
3,597
+1,102
+44% +$89K ﹤0.01% 1699
2024
Q1
$204K Buy
+2,495
New +$195K ﹤0.01% 1769
2023
Q1
Sell
-3,350
Closed -$206K 838
2022
Q4
$206K Buy
+3,350
New +$225K ﹤0.01% 629

Other funds holding HQY

Cresset Asset Management's HQY Position: Q2 2026 in Review

Cresset Asset Management increased its HealthEquity (HQY) stake by 5% in Q2 2026, buying an estimated $13.2K and bringing the position to 3,257 shares worth $294K. The position accounts for ﹤0.01% of the portfolio, ranked #1396.

Cresset Asset Management first reported a position in HQY in Q4 2022 and has held it in 11 quarters since. The position peaked at $473K in Q1 2025. 496 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Cresset Asset Management held 3,257 shares of HealthEquity worth $294K as of Q2 2026.
  • Cresset Asset Management bought 156 HealthEquity shares in Q2 2026, an estimated $13.2K.
  • HealthEquity made up ﹤0.01% of Cresset Asset Management's portfolio in Q2 2026, its #1396 holding.
  • Cresset Asset Management first reported a position in HealthEquity in Q4 2022 and has held it in 11 quarters since.
  • Cresset Asset Management's HealthEquity position peaked at $473K in Q1 2025.
  • 496 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.